4//SEC Filing
Latour Wouter 4
Accession 0001437749-21-011553
CIK 0000072444other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:05 PM ET
Size
22.3 KB
Accession
0001437749-21-011553
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Latour Wouter
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2021-05-06$1.70/sh+100,000$170,000→ 100,000 total - Exercise/Conversion
Common Stock
2021-05-07$1.70/sh+100,000$170,000→ 100,000 total - Sale
Common Stock
2021-05-06$6.54/sh−100,000$653,890→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-05-06−100,000→ 800,000 totalExercise: $1.70Exp: 2030-03-23→ Common stock (100,000 underlying) - Sale
Common Stock
2021-05-07$7.13/sh−100,000$712,750→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2021-05-07−100,000→ 700,000 totalExercise: $1.70Exp: 2030-03-23→ Common stock (100,000 underlying)
Footnotes (1)
- [F1]31.25% of the shares subject to this stock option vested on June 8, 2020, the grant date, with the remaining 68.75% vesting in 22 equal monthly installments on the first day of each calendar month thereafter, such that the option shall be fully vested on April 1, 2022.
Documents
Issuer
Vaxart, Inc.
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001652203
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:05 PM ET
- Size
- 22.3 KB